Home Tags PROCLAIM-CX-072

Tag: PROCLAIM-CX-072

CytomX Therapeutics Acquires Technologies Developed by Agensys

Clinical-stage and oncology-focused biopharmaceutical company CytomX Therapeutics, pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, has acquired...

DOWNLOAD